# Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer

> **NCT07391345** · NA · RECRUITING · sponsor: **Viktoras Rudzianskas** · enrollment: 105 (estimated)

## Conditions studied

- Laryngeal Neoplasm
- Glottic Carcinoma

## Interventions

- **PROCEDURE:** Transoral CO₂ laser cordectomy (Type I-VI depending on tumor localization)
- **RADIATION:** VMAT radiotherapy
- **RADIATION:** MRI-SABR

## Key facts

- **NCT ID:** NCT07391345
- **Lead sponsor:** Viktoras Rudzianskas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2029-09
- **Final completion:** 2034-03
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07391345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07391345, "Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07391345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*